Viewing Study NCT04806451

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-10 @ 8:55 PM
Study NCT ID: NCT04806451
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-05
First Post: 2021-03-16
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Sponsor: Neurocrine Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congenital Adrenal Hyperplasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None classic congenital adrenal hyperplasia (CAH) View
None 21-hydroxylase deficiency View